Evidence map›Paper›PMID 38979279›Full record

ArticlebioRxiv : the preprint server for biology2024

A broadly-neutralizing antibody against

Francesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, Victoria O'Dowd, Amar Parvate, Heather Callaway, Chitra Hariharan, Dipti Parekh, Sean Hui, Kelly Shaffer and 11 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Francesca R DonnellanDepartment of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK.
Vamseedhar RayaproluCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Pramila RijalCenter for Translational Immunology, Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford, OX3 7BN, UK.
Victoria O'DowdUCB Pharma, 208 Bath Road, Slough, SL1 3WE, UK.
Amar ParvateCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Heather CallawayCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Chitra HariharanCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Dipti ParekhCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Sean HuiCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Kelly ShafferCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Ruben Diaz AvalosCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Kathryn HastieCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Lisa SchimanskiMRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK.
Helena Müller-KräuterInstitute of Virology, Philipps University Marburg, Hans-Meerwein-Straße 2, 35043 Marburg, Germany.
Thomas StreckerInstitute of Virology, Philipps University Marburg, Hans-Meerwein-Straße 2, 35043 Marburg, Germany.
Ariane BalaramInfluenza Research Institute, School of Veterinary Medicine, University of Wisconsin, Madison, WI, 53713, USA.
Peter HalfmannInfluenza Research Institute, School of Veterinary Medicine, University of Wisconsin, Madison, WI, 53713, USA.
Erica Ollmann SaphireCenter for Vaccine Innovation, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Daniel J LightwoodUCB Pharma, 208 Bath Road, Slough, SL1 3WE, UK.
Alain R TownsendCenter for Translational Immunology, Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford, OX3 7BN, UK.
Simon J DraperDepartment of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK.

Funding

Mechanistic Virology CoreU19AI109762 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SAPHIRE, ERICA OLLMANN · 2014 to 2018
$29.6M
NIAID NIH HHS U19 AI109762Wellcome Trust
6 · The paper itself

Abstract

Ebolavirus disease (EVD) is caused by multiple species of

Identifiers

PMID38979279
PMCPMC11230233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.